Exciva GmbH
PrivateLast Round
Series B
Jan 20, 2026
Total Funding Raised
$72M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Exciva GmbH is a biopharmaceutical company that develops clinical-stage therapeutics for neuropsychiatric conditions, with a primary focus on agitation in patients with Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exciva GmbH Comparables
Compare Exciva GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| H. Lundbeck A/S | 79% | |
| IGC Pharma, Inc. | 78% | |
| Johnson & Johnson | 77% | |
Exciva GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 20, 2026 | ||||
| Series A | Oct 26, 2021 |
Exciva GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series B |
| Dolby Family Ventures | Series B |
| Gimv | Series B |
| Andera Partners | Series B, Seed, Series A |
| Fountain Healthcare Partners | Series B |
| Landesbank Baden-Württemberg | Series B |
| Cure8 Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
$59M round completed.
- Jun 1, 2025
Monthly visitors grew 63% MoM, from 319 to 521.
Exciva GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exciva GmbH's valuation, stock price, and market status.